Literature DB >> 6160651

The use of fluorescein diacetate and ethidium bromide as a stain for evaluating viability of mycobacteria.

J L Jarnagin, D W Luchsinger.   

Abstract

A method for evaluating the viability of mycobacterial cultures using fluorescein diacetate and ethidium bromide is described. Smears from 2-4 week old cultures of mycobacteria were stained with a 0.005% Dubos albumin broth dilution of fluorescein diacetate for thirty minutes at 37 C. The smears were counterstained with a 0.005% aqueous solution of ethidium bromide for ten minutes at room temperature and blotted dry. One drop of glycerol was placed on the smear and covered with a 22 X 40 mm coverslip. Stained smears were observed with fluorescence microscopy at 450 X. Viable organisms hydrolyzed the fluorescein diacetate and appeared yellow-green while dead organisms absorbed the ethidium bromide and appeared red-orange. Aliquots of material from which the slides were made were concurrently placed on Lowenstein-Jensen media and cultured for growth as a confirmation of viability. Investigation of 104 mycobacterial isolates using the described test showed that the viability of mycobacterial cultures can be determined by this method.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6160651     DOI: 10.3109/10520298009067249

Source DB:  PubMed          Journal:  Stain Technol        ISSN: 0038-9153


  28 in total

1.  Immunological and pathological comparative analysis between experimental latent tuberculous infection and progressive pulmonary tuberculosis.

Authors:  A K Arriaga; E H Orozco; L D Aguilar; G A W Rook; R Hernández Pando
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

2.  Immunogenicity and protection induced by a Mycobacterium tuberculosis sigE mutant in a BALB/c mouse model of progressive pulmonary tuberculosis.

Authors:  Rogelio Hernandez Pando; Leon Diana Aguilar; Issar Smith; Riccardo Manganelli
Journal:  Infect Immun       Date:  2010-05-10       Impact factor: 3.441

3.  Expression of cyclooxygenase-2, alpha 1-acid-glycoprotein and inducible nitric oxide synthase in the developing lesions of murine leprosy.

Authors:  Mayra Silva Miranda; Kendy Wek Rodríguez; Erasmo Martínez Cordero; Oscar Rojas-Espinosa
Journal:  Int J Exp Pathol       Date:  2006-12       Impact factor: 1.925

4.  Use of hoechst dyes 33258 and 33342 for enumeration of attached and planktonic bacteria.

Authors:  J H Paul
Journal:  Appl Environ Microbiol       Date:  1982-04       Impact factor: 4.792

Review 5.  Survival strategies of bacteria in the natural environment.

Authors:  D B Roszak; R R Colwell
Journal:  Microbiol Rev       Date:  1987-09

6.  Transfer factors as immunotherapy and supplement of chemotherapy in experimental pulmonary tuberculosis.

Authors:  R A Fabre; T M Pérez; L D Aguilar; M J Rangel; I Estrada-Garcìa; R Hernández-Pando; S Estrada Parra
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

7.  Rapid susceptibility testing of Mycobacterium tuberculosis (H37Ra) by flow cytometry.

Authors:  M A Norden; T A Kurzynski; S E Bownds; S M Callister; R F Schell
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

8.  In situ analysis of lung antigen-presenting cells during murine pulmonary infection with virulent Mycobacterium tuberculosis.

Authors:  Alexander Pedroza-González; Gina S García-Romo; Diana Aguilar-León; Juana Calderon-Amador; Raquel Hurtado-Ortiz; Hector Orozco-Estevez; Bart N Lambrecht; Iris Estrada-García; Rogelio Hernández-Pando; Leopoldo Flores-Romo
Journal:  Int J Exp Pathol       Date:  2004-06       Impact factor: 1.925

9.  Toxic effect of the peroxidase-hydrogen peroxide-halide antimicrobial system on Mycobacterium leprae.

Authors:  S J Klebanoff; C C Shepard
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

10.  The antipsychotic thioridazine shows promising therapeutic activity in a mouse model of multidrug-resistant tuberculosis.

Authors:  Dick van Soolingen; Rogelio Hernandez-Pando; Hector Orozco; Diana Aguilar; Cecile Magis-Escurra; Leonard Amaral; Jakko van Ingen; Martin J Boeree
Journal:  PLoS One       Date:  2010-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.